| Literature DB >> 35892489 |
Egbert Gedat1,2, Jörn Berger2, Denise Kiesel3, Vieri Failli2, Andreas Briel2, Pia Welker3.
Abstract
Rheumatologists in Europe and the USA increasingly rely on fluorescence optical imaging (FOI, Xiralite) for the diagnosis of inflammatory diseases. Those include rheumatoid arthritis, psoriatic arthritis, and osteoarthritis, among others. Indocyanine green (ICG)-based FOI allows visualization of impaired microcirculation caused by inflammation in both hands in one examination. Thousands of patients are now documented and most literature focuses on inflammatory arthritides, which affect synovial joints and their related structures, making it a powerful tool in the diagnostic process of early undifferentiated arthritis and rheumatoid arthritis. However, it has become gradually clear that this technique has the potential to go even further than that. FOI allows visualization of other types of tissues. This means that FOI can also support the diagnostic process of vasculopathies, myositis, collagenoses, and other connective tissue diseases. This work summarizes the most prominent imaging features found in FOI examinations of inflammatory diseases, outlines the underlying anatomical structures, and introduces a nomenclature for the features and, thus, supports the idea that this tool is a useful part of the imaging repertoire in rheumatology clinical practice, particularly where other imaging methods are not easily available.Entities:
Keywords: fluorescence optical imaging; image analysis; image feature; indocyanine green fluorescence; optical diagnosis imaging; rheumatoid diseases
Year: 2022 PMID: 35892489 PMCID: PMC9331249 DOI: 10.3390/diagnostics12081775
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1The 51 y/o male volunteer without clinical signs of inflammation. Signal enhancement is seen in the fingertips (f) and a slight signal enhancement in the muscle–tendon junctions (Y).
Figure 2The 45 y/o male patient with clinical diagnosis of rheumatoid arthritis. Signal enhancement seen in MCP (M), PIP (P), carpal articulation region (C), extensor carpi ulnaris (e) region, and venous vessels (V).
Figure 3The 55 y/o female patient with clinical diagnosis of osteoarthritis. Signal enhancement seen around the joint capsules (O), in the connective tissue of the entheses (E) and tendons (B) of the fingers with a maximum in P2. Signal enhancement of the muscle–tendon junctions (Y) is visible in P3.
Figure 4The 59 y/o female patient with clinical diagnosis of fibromyalgia. Signal enhancement seen in muscle–tendon junctions (Y), tendons (B), deeper muscular structures (m), and entheses (E) with irregular nail beds (I).
Figure 5The 58 y/o female patient with clinical diagnosis of CREST. Signal alteration include Raynaud’s phenomenon (R), delayed inflow in all fingertips of both hands, punctual (F), and cloudy (W) signals in P1.
Figure 6The 68 y/o male patient with clinical diagnosis Lyme borreliosis. Punctual (F) and cloudy (W) signals and irregular dye flow in the fingertips (I) can be seen during P1, with slight accumulation of the dye in the entheses and tendons (E), seen during P2.
Figure 7Left panel: the 37 y/o female patient with psoriasis arthritis. Signal enrichment is seen in DIP (D), PIP (P), MCP (M), and sigmoid patterns (a) below the nail bed. Right panel: the 45 y/o male patient with psoriasis vulgaris. Cloudy signal enrichment (W) is seen at the back of the hands and forearms, and in the psoriasis plaques (yellow arrows) with decreased signal in keratinized plaque (red arrow), as well as Raynaud’s syndrome (R).
Selected features seen in FOI images.
| Region | Name | Description | Figure |
|---|---|---|---|
| Fingers | f | Round or slightly oval signal in fingertips, physiological |
|
| r | Delayed inflow in all fingertips (in both hands) |
| |
| R | Diminished or non-existent flow of the dye into one or more fingers (Raynaud syndrome) | ||
| Nails | a | Sigmoid outflow of the dye from the nailbed |
|
| I | Irregular (inhomogeneous) signal in the nail bed | ||
| Joints | D | Round, oval, mostly regularly shaped signal (DIP joints) |
|
| P | Round, oval, mostly regularly shaped (PIP joints) | ||
| M | Round, oval, o mostly regularly shaped (MCP joints) | ||
| C | Round, oval, mostly regularly shaped (Intercarpal joints) |
| |
| O | Signal around joints, most likely the fibrous membrane, or aponeurosis |
| |
| Venous vessels | V | Signal on the back of the hand, in the area of superficial venous structures |
|
| Connectivetissue | E | Triangle shaped signal enhancement below nail | |
| B | Broad, pronounced signals in the area of dorsal tendons | ||
| Y | Increased signals in the area of muscle tendon junction of wrist | ||
| e | Increased signals in the extensor carpi ulnaris region |
| |
| Muscle | m | Varying intensity and signal sharpness depending on the depth |
|
| Skin, connective tissue with blood vessels | W | Cloudy, “unsharp” signal | |
| F | Punctual, “sharp” signal, or irregularly shaped |
Signal distribution pattern in the NIR-FOI of the hands of patients with rheumatic diseases.
| Region | Name | Tissue | Visible in Phase | Depth of Location | Perfusion |
|---|---|---|---|---|---|
| Fingers | f, I | Capillary network in the nail bed | Phase 1 | Superficial | High |
| R | Sclerosed or necrotic tissue, keratinized plaques | Phases 2 and 3 | Superficial | Low | |
| Joints | D, P, M, C | Capillary network of the synovial membrane | Phases 1 and 2 | Superficial/Deep | High |
| Vessels | V | Large veins on the back of the hand | Phases 2 and 3 | Superficial | High |
| Connectivetissue | E, B | Tight connective tissue of dorsal entheses, tendons, aponeuroses | Phases 2 and 3 | Deep | Low |
| Y | Connective tissue/muscle | Phases 2 and 3 | Superficial | Low/High | |
| e | ECU tendon | Phases 1 and 2 | Superficial | Low | |
| a | Entheses and tendons between nailbed and DIP | Phases 2 and 3 | Deep | Low | |
| Muscle | m | Muscle tissue | Phase 3 | Deep | High |
| Skin, connective tissue | W, F | Arteries/capillaries | Phase 1 | Superficial/Deep | High |